With the development and application of advanced materials and new techniques in recent years, encouraging achievements have been made in endovascular therapy of arteriosclerosis obliterans of the lower extremities. In this paper, the author summarizes the advances from recent related controlled clinical trials, and suggests the existing problems and future prospects.